HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metformin as a booster or obstacle of immunotherapy in patients with non-small cell lung cancer and diabetes mellitus.

AuthorsMing-Cheng Guan, Qian Ding, Jing Ning, Hong Zhu
JournalCancer (Cancer) Vol. 130 Issue 2 Pg. 322-323 (01 2024) ISSN: 1097-0142 [Electronic] United States
PMID37987230 (Publication Type: Letter, Research Support, Non-U.S. Gov't, Comment)
Chemical References
  • Metformin
  • Hypoglycemic Agents
Topics
  • Humans
  • Carcinoma, Non-Small-Cell Lung (drug therapy)
  • Metformin (therapeutic use)
  • Lung Neoplasms (drug therapy)
  • Diabetes Mellitus, Type 2
  • Immunotherapy (adverse effects)
  • Hypoglycemic Agents (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: